David V.
- Country
- Spain
- Department
- Hematologia
Research Overview
- A Phase 2/3, Multicenter, Randomized, Dose Optimization (Part I), Double-blind (Part II) Study to Compare the Efficacy and Safety of Oral Azacitidine (Oral-Aza, ONUREG®) plus Best Supportive Care (BSC) versus Placebo plus BSC in Participants with IPSS-R Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)
- A Phase 2a/2b, Open-label, Proof of Concept (Phase 2a) and Open-label (Phase 2b), Multicenter, Efficacy, and Safety Study of AG-946in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes
- Phase 3 Randomized Open‑Label Study of Elritercept Versus Epoetin Alfa for Anemia in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndromes Requiring RBC Transfusions
Data & Insights
Has run more than one trial at 179 of 333 partner sites.
Specializations
Hematologic Disorders
The investigator specializes in treating myelodysplastic syndromes (MDS) with particular emphasis on lower-risk disease variants. Their research encompasses innovative therapeutic approaches for patients with non-transfusion-dependent conditions.
- Lower-risk MDS management
- Novel therapeutic agents in MDS
- Anemia treatment strategies
A key focus includes evaluating treatment responses in MDS patients using established international working group criteria.
Hepatic Complications
The investigator demonstrates expertise in treating patients with myeloid malignancies complicated by varying degrees of liver dysfunction. Their work addresses the challenges of managing patients with concurrent hepatic impairment.
- Hepatic function assessment
- Cancer treatment adaptation
- Organ dysfunction management
Their research considers the impact of liver function on treatment approaches for hematologic conditions.
Treatment Innovation
The investigator explores novel therapeutic strategies for hematologic disorders, with particular attention to comparing established treatments with emerging therapies. Their work includes evaluation of various treatment modalities for blood disorders.
- Comparative treatment studies
- Clinical efficacy assessment
- Patient response monitoring
Their research encompasses both traditional and innovative approaches to treating hematologic conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.